Italy: anti-diabetes drugs market revenue forecast 2027

The revenue of the Anti-Diabetes Drugs industry in Italy is forecast to continuously increase within the next years. After tenth consecutive increasing years, the revenue is estimated to reach 0.81 billion euros and therefore a new peak in 2027. This statistic shows the forecast of the anti-diabetes drugs market revenue in Italy from 2017 to 2027 (in billion euros).

Forecast of the anti-diabetes drugs market revenue in Italy from 2017 to 2027 (in billion euros)

Characteristic	Revenue in billion euros
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

This includes the drugs to treat diabetes mellitus (oral intake and injections), insulin, non-insulinotropic anti-diabetic drugs.
And excludes the drugs to treat other metabolic disorders or other autoimmune diseases, lipid-lowering agents, drugs to treat hypertension, diagnostics, devices such as continuous glucose monitors.
All figures are estimates.
A detailed methodology can be found in the Statista Health Market Outlook.

Citation formats